| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Feb 20, 2026 | Tax withholding(F) | 14K | $19.66 | $274K | 264K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001898490-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Theravance Biopharma, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.